non-nucleoside analog


Also found in: Medical.
Related to non-nucleoside analog: Nucleoside reverse transcriptase inhibitors

non-nu·cle·o·side analog

 (nŏn-no͞o′klē-ə-sīd′, -nyo͞o′-)
n.
Any of a diverse group of antiviral agents, including reverse transcriptase inhibitors such as delavirdine, that are structurally distinct from nucleosides.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
All patients were exposed to at least two ARV including: nucleoside analog reverse transcriptase inhibitors (NRTIs), non-nucleoside analog reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).
Differences in ARV exposure by HIV-1 subtype ARV Exposure Subtype B Subtype C Subtype F Average number of ARVs 6.95 * 6.32 * 7.12 Average number 4.34 * 3.66 * 4.48 of regimen Proportion of NRTI 44.8% 33.8% 36.8% double therapy exposure Average duration of 74 months 62 months ** 73 months thymidines exposure Average duration of 10 months 10 months 12.5 months NNRTI exposure Average duration of 60 months 39.5 months ** 65 months PI exposure ARV, antiretroviral; NNRTI, non-nucleoside analog reverse transcriptase inhibitors; PI, protease inhibitors.
Full browser ?